No Data
No Data
The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
CCORF Maintains Inari Medical(NARI.US) With Buy Rating, Maintains Target Price $71
Earnings Update: Inari Medical, Inc. (NASDAQ:NARI) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Inari Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Baird Maintains Inari Medical(NARI.US) With Buy Rating, Cuts Target Price to $63
Express News | Inari Medical Shares Are Trading Lower After the Company Reported Q2 Financial Results and Issued FY24 Revenue Guidance Below Estimates. Also, Truist Securities and Baird Lowered Their Respective Price Targets on the Stock